CryoDerm Heat
Natural health product licensed in Canada
- Licence holder
- AHC Ventures Inc.
- NPN or DIN-HM
- 80032900
- Status
- Active licence
- Licence date
- 18 June 2012
- Revision date
- Not provided
- Form
- Lotion
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| dl-Camphre Source : dl-Camphre | 3.85 % |
| (E)-8-Méthyl-N-vanillyl-6-nonenamide Source : Capsaïcine | 0.0355 % |
Non-medicinal ingredients
Eau de fleur de Rosa Damascena, Extrait de Boswellia Serrata, MSM, Alcool cétéarylique, Extrait de fleur d'Arnica montana, Glucoside de cétéaryle, Extrait de citrus grandis (pamplemousse), Phénoxyéthanol, Extrait de fruit de Citrum Aurantium Dulcis (Oranger), Jus de feuilles d'Aloe Barbadensis, Ethylhexylglycérine, d-alpha tocophérol, Triéthanolamine, Extrait de feuille/racine/tige de Yucca Schidigera, Glycérine, Aqua, Carbomère 980, extrait de feuilles de Ilex paraguayensis ( extrait de feuilles d'herbe du Paraguay)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et enfants | minimum: 2 years | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Temporarily relieves aches and pains associated with: arthritis, simple backache, muscle strains, muscle sprains. Temporarily relieves aches and pains of muscles and joints associated with strains and sprains, involving muscles, tendons and ligaments.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80032900
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.